Role of Clinical Pharmacist to Reduce Risk in Patients Involving Antiretroviral Drugs at Abidjan Cohort

Djadji ATL^1,2*, Kamenan BAT^1,5, Kassi NAC^2,3, Guehi C⁴, Bekegran C^1,2 and Eholie SP^2,3

¹Clinical Pharmacy and Therapeutic laboratory, Pharmaceutical and Biological Faculty, Felix Houphouet Boigny’s University at Abidjan, Côte d’Ivoire 01 BPV 34 Abidjan, Ivory Coast

²Infectious and Tropical Diseases Unit of Treichville teaching Hospital at Abidjan, Côte d’Ivoire 01 BPV 03 Abidjan, Ivory Coast

³Medical Sciences Department, Felix Houphouet Boigny’s University at Abidjan, Côte d’Ivoire 01 BPV 34 Abidjan, Ivory Coast

⁴Advises and outpatient care Unit at Abidjan, Côte d’Ivoire, Ivory Coast

⁵Unit of Pneumophtisiology Cocody Teaching Hospital Abidjan, Ivory Coast

^*Corresponding Author: Djadji ATL, Clinical Pharmacy and Therapeutic laboratory, Pharmaceutical and Biological Faculty, Felix Houphouet Boigny’s University at Abidjan, 01 BPV 34 Abidjan 01, Cote D'Ivoire